Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 31-40 of 84

Page
per page
  1. Divalproex Sodium
    B1391 Divalproex Sodium
    Summary: Epilepsy/migraines/bipolar disorder medicine
      ≥14.2 mg/mL
  2. Pepstatin A
    A2571 Pepstatin A
     1 Citation
    Target: Cathepsins|Renin|HIV proteases|Pepsins
    Summary: Aspartic protease inhibitor
      ≥34.3 mg/mL
  3. MG-262
    A8179 MG-262
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      ≥24.57 mg/mL
  4. DUBs-IN-2
    B3515 DUBs-IN-2
    Summary: deubiquitinase enzyme inhibitor
      ≥17.03 mg/mL
  5. DUBs-IN-3
    B3516 DUBs-IN-3
    Summary: potent deubiquitinase enzyme inhibitor
      Soluble in DMSO
  6. Vinblastine sulfate
    A3920 Vinblastine sulfate
     2 Citation
    Summary: Anti-mitotic agent
      ≥28.85 mg/mL
  7. P 22077
    A8198 P 22077
    Summary: USP7/(DUB)USP47 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥14.6 mg/mL
  8. P005091
    A3023 P005091
     1 Citation
    Target: Ubiquitin-specific proteases
    Summary: Ubiquitin-specific protease 7 (USP7) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.4 mg/mL
  9. IU1
    A4002 IU1
    Summary: Usp14 inhibitor
      insoluble in H2O; ≥10.9 mg/mL
  10. LDN 57444
    A4003 LDN 57444
    Target: UCH
    Summary: UCH-L1 inhibitor,reversible competitve
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL

Items 31-40 of 84

Page
per page